These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7591556)

  • 1. Cost-effectiveness studies of renal transplantation.
    Karlberg I; Nyberg G
    Int J Technol Assess Health Care; 1995; 11(3):611-22. PubMed ID: 7591556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 4. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost effectiveness of renal provision in the UK.
    Haycox A; Jones D
    J Manag Med; 1996; 10(1):6-15. PubMed ID: 10162928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil.
    Sesso R; Eisenberg JM; Stabile C; Draibe S; Ajzen H; Ramos O
    Int J Technol Assess Health Care; 1990; 6(1):107-14. PubMed ID: 2113888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL).
    Garcia-Garcia G; Monteon-Ramos JF; Garcia-Bejarano H; Gomez-Navarro B; Reyes IH; Lomeli AM; Palomeque M; Cortes-Sanabria L; Breien-Alcaraz H; Ruiz-Morales NM
    Kidney Int Suppl; 2005 Aug; (97):S58-61. PubMed ID: 16014102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal care in developing countries: the India experience.
    Jha V
    Ren Fail; 2004 May; 26(3):201-8. PubMed ID: 15354966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage renal disease in India and Pakistan: burden of disease and management issues.
    Sakhuja V; Sud K
    Kidney Int Suppl; 2003 Feb; (83):S115-8. PubMed ID: 12864888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
    Wikström B; Fored M; Eichleay MA; Jacobson SH
    Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness analysis of alternative treatments of end-stage renal disease: Philippine experience.
    Naidas OD; Chan-Licuanan KR; Velasco VP; Dalay CV; Bayog DV; Rosete-Liquete RM
    Transplant Proc; 1998 Nov; 30(7):3116. PubMed ID: 9838375
    [No Abstract]   [Full Text] [Related]  

  • 14. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of renal replacement therapies in Finland.
    Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
    Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economics of dialysis and renal transplantation in the developing world.
    Chugh KS; Jha V; Chugh S
    Transplant Proc; 1999 Dec; 31(8):3275-7. PubMed ID: 10616473
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost comparison of kidney transplant versus dialysis in Brazil.
    Silva SB; Caulliraux HM; Araújo CA; Rocha E
    Cad Saude Publica; 2016 Jun; 32(6):. PubMed ID: 27383457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
    Ferguson TW; Tangri N; Rigatto C; Komenda P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary.
    Kaló Z; Járay J; Nagy J
    Prog Transplant; 2001 Sep; 11(3):188-93. PubMed ID: 11949461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.